Lightchain Capital

Recent News

wugen-logo-400
March 08, 2021

Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer

READ MORE
wugen-logo-400
March 04, 2021

https://www.technologynetworks.com/biopharma/articles/the-promise-of-natural-killer-cells-346227

READ MORE
Logo-Geneoscopy-400
March 03, 2021

Geneoscopy Appoints Vince Wong as Chief Commercial Officer

READ MORE
wugen-logo-400
March 02, 2021

St. Louis biotech startup Wugen inks manufacturing deal, hires C-suite exec

READ MORE
C4-logo-400
February 24, 2021

C4 Therapeutics to Participate in Upcoming March Investor Conferences

READ MORE
wugen-logo-400
February 22, 2021

Wugen Announces Exclusive License Agreement for their Memory Natural Killer (NK) Cell-based Therapy Program with Washington University in St. Louis

READ MORE
wugen-logo-400
February 22, 2021

Wugen Appoints Jan Davidson M.D., Ph.D., as Chief Medical Officer to Guide the Company’s Global NK and T cell Clinical Programs

READ MORE
C4-logo-400
February 11, 2021

C4 Therapeutics to Participate in BMO BioPharma Spotlight Series

READ MORE
CareVet-Logo-New
February 11, 2021

Krishna Walker – CareVet

READ MORE

Contact Us

Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131

 

LinkedIn

Submit

©2024 LIGHTCHAIN CAPITAL, LLC  All Rights Reserved | Privacy Policy
Website by Tidal Media Group